APA (7th ed.) Citation

Fleischmann, M., Diefenhardt, M., Nicolas, A. M., Rödel, F., Ghadimi, M., Hofheinz, R., . . . Fokas, E. (2022). ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group. Elsevier.

Chicago Style (17th ed.) Citation

Fleischmann, Maximilian, Markus Diefenhardt, Adele M. Nicolas, Franz Rödel, Michael Ghadimi, Ralf-Dieter Hofheinz, Florian R. Greten, Claus Rödel, and Emmanouil Fokas. ACO/ARO/AIO-21 - Capecitabine-based Chemoradiotherapy in Combination with the IL-1 Receptor Antagonist Anakinra for Rectal Cancer Patients: A Phase I Trial of the German Rectal Cancer Study Group. Elsevier, 2022.

MLA (9th ed.) Citation

Fleischmann, Maximilian, et al. ACO/ARO/AIO-21 - Capecitabine-based Chemoradiotherapy in Combination with the IL-1 Receptor Antagonist Anakinra for Rectal Cancer Patients: A Phase I Trial of the German Rectal Cancer Study Group. Elsevier, 2022.